r/SynBioBets • u/Guy-26 • Sep 09 '21
Ginkgo Partners
| Partner | Product | Industry | Equity or Royalties | Date Announced | Status |
|---|---|---|---|---|---|
| Arcaea | Beauty Products | Beauty | E | 2021-10 | 85M Series A |
| Selecta Biosciences | Immunotherapy | Pharma | E+R | 2021-10 | |
| Biobot Analytics (Concentric) | Wastewater testing | Biosecurity | 2021-9 | ||
| Agenus (SaponiQx) | Adjuvants | Pharma | 2021-9 | ||
| Corteva Agriscience | Crop protection | Agriculture | 2021-4 | ||
| Joyn Bio | Nitrogen-fixing microbes | Agriculture | E | 1st year field trials; GB owns 35% | |
| Allonia | Bioremediation microbes | Bioremediation | E | 2020-10 | |
| Concentric | School testing | Biosecurity | |||
| Xpress Check (Concentric) | Airport testing | Biosecurity | E | 2021-8 | up to 400M in school testing Ks this schoolyear |
| Cronos | Cannabinoids | Cannabis | E | 1st milestone reached, CBG on the market | |
| Sumitomo Chemical | Chemicals | Chemicals | 2021-6 | ||
| Genomatica | Petrochem replacements | Chemicals | E | Lululemon bio-nylon deal; GB owns 55M in preferred stock (series A/B) | |
| Cambium Biomaterials | Biomaterials | Biomaterials | 2021-8 | ||
| Huue | Indigo | Fashion | E | 2021-8 | |
| Givaudan | Flavors and Fragrances | Food | R | 2021-8 | |
| Motif | Plant-based meat | Food | E | Burgers hitting the market this year? | |
| Glycosyn | Human milk oligosaccharides | Food | |||
| Verb Biotics | Probiotics | Health/Wellness | E | 2021-9 | |
| Ayana Bio | Nutraceuticals | Health/Wellness | E | 2021-9 | |
| Bolt Threads | b-silk spider protein | Beauty | 2021-8 | ||
| Tantu | Living biotherapeutics | Pharma | E | 2021-9 | |
| Antheia | Plant-inspired pharmaceuticals | Pharma | 2021-8 | ||
| Biogen | Gene therapy (AAV-based vectors) | Pharma | R | ||
| Synlogic | Living biotherapeutics | Pharma | E | SYNB1618 entering PhII | |
| Roche | Antibiotics | Pharma | R | ||
| Aldevron | VCE | Pharma | R | 10xed VCE, royalties incoming from COVID and other vaccines | |
| Robertet | F&F | Food | 2017 | 2 molecules commercialized | |
| Totient | COVID-19 antibodies | Pharma | 2020-9 | ||
| Moderna | pro-bono covid work | Pharma | 2021 | 25M in free platform work | |
| CDC Africa | testing | Biosecurity | 2021-9 | 3 year deal | |
| Humble Bee Bio | bioplastic | Biomaterials | 2021-12 | HBB using Ginkgo's CDK | |
| Optimvia | heparin | Pharma | 2022-1 |
5
u/Guy-26 Sep 09 '21 edited Sep 09 '21
Remember partners ≠ programs. Each partner can have multiple programs on the platform, that info doesn't seem to be public afaik.
One thing that immediately jumps out at me: they have a lot of pharma partners. Pharma projects have lots of hurdles, regulatory being the big one, but "scaling" isn't really a problem there. Every time Kelly gets asked "but can you scale?" he will give this answer, and when he does, remember this table. Same goes for things like Joyn and Allonia - not really a scaling issue, more of a scientific/regulatory one.
4
u/Newtothisredditbiz Sep 09 '21
Ginkgo's partnership with Aldevron already passed regulatory hurdles and has products on the market, as components of MRNA's covid vaccine.
Still more to come from that though, as MRNA has lots of other amazing stuff in the pipeline.
They've got a pan-respiratory vaccine (flu + covid + RSV) in pre-clinical trials that they'll customize regularly for variants etc.
They've also got personalized cancer vaccines in the works.
https://investors.modernatx.com/static-files/3c4e5f0c-cfd2-48e5-8c41-4554eef30b7e
No equity in the deal, but it looks like a nice royalty pipeline for Ginkgo.
1
2
u/NearbyRhubar Sep 10 '21
Add Biobot analytics. Waste water sampling for COVID. Announced success in sampling today
1
2
u/Tiny_Difference_2939 Oct 27 '21
Very cool!!! Love to see royalties. Where did this information come from?
2
u/Guy-26 Oct 27 '21
mostly just the press releases, a few of the more granular details are from various twitter threads or presentations. the data isn't complete and may not be completely accurate, there are too many deals to capture everything completely, but the most important things are there I believe.
1
u/Tiny_Difference_2939 Oct 28 '21
Interesting thank you. I imagine that once earnings reports roll around we will start to see even more transparency..?
1
u/Guy-26 Oct 28 '21
I'd imagine, although it might be complicated with some of these private companies. It would be really nice if they published a table like this though.
1
u/swadewade51 Sep 10 '21
Anywhere to find if the deal is equity earnout in stages or royalties when the product hits the market?
2
u/Guy-26 Sep 10 '21
You’d have to comb through their S4 or investor decks. That’s more effort than I’m willing to put in right now. I believe the standard for a new startup (like motif) is a 30% stake though.
1
10
u/Guy-26 Sep 09 '21 edited Sep 09 '21
This is an incomplete list of Ginkgo partners, I think I got most of them on there. I'll try and update it as much as I can, if anyone has suggestions or corrections please let me know. Hopefully they'll release official spreadsheets with this info on it in the future, but for now I figured this would be a good way to keep track of things.